A medical worker, checks an oxygen cylinder before transferring COVID-19 patient from the emergency ward to the Intensive Care Unit (ICU) of Jawahar Lal Nehru Medical College and Hospital, Bihar, India, 27 July 2020.
A medical worker, checks an oxygen cylinder before transferring COVID-19 patient from the emergency ward to the Intensive Care Unit (ICU) of Jawahar Lal Nehru Medical College and Hospital, Bihar, India, 27 July 2020.Reuters file photo

India’s tally on Wednesday crossed 56 lakh cases following a spike of 83,347 fresh coronavirus infections reported in 24 hours, according to data from the Ministry of Health and Family Welfare.

There were 1,085 new deaths as the toll in past more than eight months reached 90,020 and the total cases mounted to 5,646,010.

India is the second worst hit country by the pandemic just behind the US, where they have recorded 200,000 deaths.

Out of the total cases in India, 968,377 are currently active, and 4,587,613 have been discharged, making the rate of recoveries best in the world.

While the recovery rate stands at 81.25 per cent, the fatality rate has come down to 1.59 per cent.

Maharashtra continues to be the worst-hit with a total of 1,242,770 cases, including 33,407 deaths, followed by Andhra Pradesh, Tamil Nadu, Karnataka and Uttar Pradesh.

Advertisement

According to the data from the Indian Council of Medical Research (ICMR), India conducted 953,683 sample tests in a single day on Tuesday, taking the total number of samples tested so far to 66,279,462.

The Union Health Ministry had said that it has increased the testing infrastructure exponentially. Till 7 July, India had tested 10 million samples and it took us 27 days to add 20 million tests. By 3 August, we had tested 3 million samples. During this period, the laboratories were increased from 1,100 to 1,300 in the country.

On Tuesday, the Indian Council of Medical Research (ICMR) said that the efficacy of the COVID-19 vaccinein India might not reach 100 per cent. “We are aiming for 100 per cent efficacy but may land between 50 to 100 per cent. However, it still would be an effective vaccine against the virus,” Balram Bhargava, ICMR director general said.